Prospective observational study of the efficacy of oral uracil and tegafur plus leucovorin for stage II colon cancer with risk factors for recurrence using propensity score matching (JFMC46-1201).
Sadahiro S, Sakamoto K, Tsuchiya T, Takahashi T, Ohge H, Sato T, Kondo K, Ogata Y, Baba H, Itabashi M, Ikeda M, Hamada M, Maeda K, Masuko H, Takahashi K, Sakamoto J, Kusano M, Hyodo I, Taguri M, Morita S.
Sadahiro S, et al.
BMC Cancer. 2022 Feb 15;22(1):170. doi: 10.1186/s12885-022-09267-z.
BMC Cancer. 2022.
PMID: 35168560
Free PMC article.
Clinical Trial.